You are here

András Csilla

András Csilla

András Csilla
DE > ÁOK
Department of Clinical Oncology
Division of Clinical Oncology
egyetemi adjunktus
Name: András Csilla
Other profiles: MTMT
Profession: oncologist

Publication list

Uploaded publications:
117
Publications in DEA:
109
OA:
20
Date range:
1996-2023
2023
  1. Bádon, E., Beke, L., Mokánszki, A., András, C., Méhes, G.: Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy.
    Int. J. Mol. Sci. 24 (3), 1-16, 2023.
    Journal metrics:
    Q2 Catalysis
    Q1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
2022
  1. Landherr, L., Pintér, T., Hornyák, L., Révész, J., Máhr, K., Torday, L., András, C., Erfán, J., Árkosy, P., Bodoky, G.: Hazai tapasztalatok metasztatikus kolorektális karcinóma bevacizumabbal kiegészített indukciós kemoterápiás kezelésével (AVACONT vizsgálat).
    Magyar Onkol. 66 (1), 2022.
    Journal metrics:
    Q4 Medicine (miscellaneous)
    Q4 Oncology
2021
  1. Magyar Hepato-Pancreatico-Biliaris (HPB) Kutatócsoport, András, C.: A hepatocellularis carcinoma komplex kezelése.
    Orv. hetil. 162 (Suppl2), 2-31, 2021.
2020
  1. Szekanecz, Z., Gomez, I., Soós, B., Bodoki, L., Szamosi, S., András, C., Juhász, B., Váróczy, L., Antal-Szalmás, P., Szodoray, P., Bittner, N., Árkosy, P., Illés, Á., Szűcs, G., Dankó, K., Bender, T., Tamási, L., Szekanecz, É., Hungarian OncoRheumatology Network (HORN) initiative: Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases.
    Autoimmun. Rev. 19 (11), 1-12, 2020.
    Journal metrics:
    Q1 Immunology
    Q1 Immunology and Allergy
  2. Kóder, G., Olasz, J., Tanyi, J., George, E., Tóth, L., Antal-Szalmás, P., Nagy, B., Bubán, T., András, C., Urbancsek, H., Laczik, M., Csuka, O., Damjanovich, L., Tanyi, M.: Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary.
    J Gastrointest Cancer. 51 (3), 1007-1015, 2020.
    Journal metrics:
    Q3 Gastroenterology
    Q3 Oncology
  3. András, C., Bodoki, L., Nagy-Vincze, M., Griger, Z., Csiki, E., Dankó, K.: Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort.
    Pathol. Oncol. Res. 26 (3), 1749-1755, 2020.
    Journal metrics:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q2 Pathology and Forensic Medicine
2019
  1. Magyar Hepato-Pancreatico-Biliaris (HPB) Kutatócsoport: Colorectalis májmetastasisok komplex kezelése.
    Orv. hetil. 160 (Supplement), 2-20, 2019.
  2. Szántó, E., Dér, Á., Balogh, I., Simon, M., András, C., Bajusz, É., Árkosy, P., Kovács, Á.: Hasnyálmirigyrák kemo-radioterápiájával szerzett kezdeti tapasztalatok.
    Magyar Onkol. 63 (Suppl.), 64, 2019.
  3. Fuchs, C., Shitara, K., Di Bartolomeo, M., Lonardi, S., Al-Batran, S., Van Cutsem, E., Ilson, D., Alsina, M., Chau, I., Lacy, J., Ducreux, M., Mendez, G., Alavez, A., Takahari, D., Mansoor, W., Enzinger, P., Gorbounova, V., Wainberg, Z., Hegewisch-Becker, S., Ferry, D., Lin, J., Carlesi, R., Das, M., Shah, M., RAINFALL Study Group: Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Lancet Oncol. 20 (3), 420-435, 2019.
2018
  1. András, C., Varga, E., Árokszállási, A., Csiki, E., Bodor, E., Árkosy, P.: A HCC kezelése sorafenib után - tapasztalatok a DE KK Onkológiai Klinikán.
    Klin. Onkol. 5/2018 (Suppl.), 23, 2018.
2017
  1. András, C., Horváth, Z.: A biliáris rendszer tumorai és kezelésük.
    Orvostovábbk. Szle. 23 (11), 35-39, 2017.
  2. Dócs, O., Dull, K., Mokánszki, A., Mónus, A., Beke, L., András, C., Bedekovics, J., Méhes, G.: Mutant KRAS Status Is Associated with Increased KRAS Copy Number Imbalance: a Potential Mechanism of Molecular Heterogeneity.
    Pathol. Oncol. Res. 23 (2), 417-423, 2017.
    Journal metrics:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q2 Pathology and Forensic Medicine
Show all
updated: 2024-07-21, 02:22

SCImago quartiles of
scientific journal articles

Number of scientific articles: 72
Q1/D1 4 (5.6%)
Q1 12 (16.7%)
Q2 20 (27.8%)
Q3 13 (18.1%)
Q4 9 (12.5%)
N/A 18 (25%)
-
OK

SCImago subject areas and categories

Medicine (51)
Medicine (miscellaneous) (38)
Oncology (17)
Pathology and Forensic Medicine (8)
Immunology and Allergy (6)
Rheumatology (6)
Gastroenterology (4)
Hematology (4)
Surgery (3)
Hepatology (2)
Cardiology and Cardiovascular Medicine (1)
Genetics (clinical) (1)
Radiology, Nuclear Medicine and Imaging (1)
Biochemistry, Genetics and Molecular Biology (16)
Cancer Research (10)
Cell Biology (3)
Molecular Biology (2)
Biochemistry (1)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (1)
Clinical Biochemistry (1)
Genetics (1)
Immunology and Microbiology (6)
Immunology (6)
Arts and Humanities (1)
History and Philosophy of Science (1)
Chemical Engineering (1)
Catalysis (1)
Chemistry (1)
Inorganic Chemistry (1)
Organic Chemistry (1)
Physical and Theoretical Chemistry (1)
Spectroscopy (1)
Computer Science (1)
Computer Science Applications (1)
Neuroscience (1)
Neuroscience (miscellaneous) (1)

Genre chart

Year chart

Language chart

Journals

Show more

iDEa co-authors

Show more

Other co-authors

Show more
Sasi Szabó László András
Abolmaali, Nasreddin
Alavez, Alejandro Molina
Al-Batran, Salah-Eddin
Boland, Mershad Ghassem
Castiglione-Gertsch, Monica
Di Bartolomeo, Maria
Hegewisch-Becker, Susanna
Lugosiné Horváth Nóra
Mendez, Guillermo Ariel